JWH-309
http://dbpedia.org/resource/JWH-309 an entity of type: Thing
JWH-309 (naphthalen-1-yl-(5-naphthalen-1-yl-1-pentylpyrrol-3-yl)methanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB1 (Ki = 41 ± 3nM) and CB2 (Ki = 49 ± 7nM) receptors, displaying a slight selectivity for the former. JWH-309 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB1 receptor.
rdf:langString
rdf:langString
JWH-309
xsd:integer
68528853
xsd:integer
1102142659
xsd:integer
30
xsd:integer
914458
rdf:langString
ID23277951
xsd:integer
27
rdf:langString
naphthalen-1-yl-methanone
rdf:langString
Class B
xsd:integer
1
xsd:integer
1
xsd:integer
44418371
rdf:langString
CCCCCN1C=CCC4=CC=CC5=CC=CC=C54
xsd:integer
1
rdf:langString
WVISOUYKTUUDFW-UHFFFAOYSA-N
xsd:integer
5
rdf:langString
JWH-309 (naphthalen-1-yl-(5-naphthalen-1-yl-1-pentylpyrrol-3-yl)methanone) is a synthetic cannabinoid from the naphthoylpyrrole family which acts as an agonist of the CB1 (Ki = 41 ± 3nM) and CB2 (Ki = 49 ± 7nM) receptors, displaying a slight selectivity for the former. JWH-309 was first synthesized in 2006 by John W. Huffman and colleagues to examine the nature of ligand binding to the CB1 receptor.
rdf:langString
Schedule II
xsd:nonNegativeInteger
3893
xsd:string
914458-42-7
xsd:string
5LC7L6AM73
xsd:string
44418371